Market closed

Medtronic/$MDT

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Medtronic

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Ticker

$MDT
Sector
Health Care

Trading on

NYSE

Industry

Health Care Equipment & Supplies

Headquarters

Galway, Ireland

Employees

95,000
Website
www.medtronic.com

Medtronic Metrics

BasicAdvanced
$105B
25.04
$3.27
0.83
$2.79
3.42%

$105B

0.83

$90.94

$75.96

6M

$2.79

1.84

1.168

50.511

58.145

84.54%

8.63%

4.53%

8.61%

25.041

3.239

2.16

-20.61

19.438

3.41%

3.42%

3.25%

6.04%

1.24%

-1.97%

4.73%

What the Analysts think about Medtronic

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Medtronic stock.

Medtronic Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Medtronic Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Medtronic News

AllArticlesVideos
Medtronic plc (MDT) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Medtronic plc (MDT) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Seeking Alpha·1 day ago
Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division

Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division

Accesswire·1 week ago
Medtronic: A Dividend Aristocrat That's Poised To Pop

Medtronic: A Dividend Aristocrat That's Poised To Pop

Seeking Alpha·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MDT

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Medtronic stock?

Medtronic (MDT) has a market cap of $105B as of January 15, 2025.

What is the P/E ratio for Medtronic stock?

The price to earnings (P/E) ratio for Medtronic (MDT) stock is 25.04 as of January 15, 2025.

Does Medtronic stock pay dividends?

Yes, the Medtronic (MDT) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $2.79 and the yield is 3.42%. Medtronic has a payout ratio of 84.54% on a trailing twelve-month basis.

When is the next Medtronic dividend payment date?

The next Medtronic (MDT) dividend payment date is unconfirmed.

What is the beta indicator for Medtronic?

Medtronic (MDT) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.